CDKN2A and neoplasm: In the remaining samples, homozygous deletions in three clinically important tumour suppressor genes, CDKN2A, MAP2K4, and PTEN occurred at analogous percentages in FF and FFPE samples (Supplementary Tables 7 and 8).